title: New directions in immunosuppression after heart transplantation.
abstract: Heart transplantation has evolved into the treatment of choice for eligible patients with end-stage heart failure. Effective immunosuppression is critical to the success of this treatment, with the modern era beginning with the advent of cyclosporin A in the 1980s. In this Perspectives article, the major prospective, randomized trials of immunosuppression after heart transplantation are briefly reviewed. These trials provided the setting for the 2011 TICTAC trial, in which combined immunosuppression was compared with monotherapy. The results of the study are discussed, as are the implications of these data for future research, including the importance of frameworks, the risks and benefits of changes in immunosuppression regimen, the future of funding for such research, and the selection of appropriate end points in trials of heart transplantation. The presupposed need for multidrug immunosuppression is challenged, and the potential efficacy and benefits of monotherapy are explored.
authors: Newark Beth Israel Medical Center, 201 Lyons Avenue, L-4, Transplant Center, Newark, NJ 07112, USA. dbaran@barnabashealth.org.
authors: David A
authors: DA
authors: Baran
mesh_terms: D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D006333:Heart Failure / Q000601:surgery*; D016027:Heart Transplantation / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents
references: Forum Med. 1980 Jul;3(7):441-5
references: 10309213
references: J Heart Lung Transplant. 2001 Jan;20(1):59-70
references: 11166613
references: Transplantation. 2006 Jun 15;81(11):1549-57
references: 16770244
references: J Heart Lung Transplant. 2006 Jun;25(6):699-706
references: 16730576
references: Circulation. 1975 Oct;52(4):531-9
references: 1098809
references: N Engl J Med. 2005 Jun 30;352(26):2705-13
references: 15987919
references: Am J Transplant. 2006 Jun;6(6):1387-97
references: 16686762
references: S Afr Med J. 1967 Dec 30;41(48):1271-4
references: 4170370
references: N Engl J Med. 2003 Aug 28;349(9):847-58
references: 12944570
references: N Engl J Med. 1980 May 8;302(19):1087-8
references: 6767980
references: Transplantation. 2002 Oct 27;74(8):1136-41
references: 12438960
references: Ann Surg. 2013 Feb;257(2):345-51
references: 23001085
references: Transplantation. 2008 Dec 27;86(12):1689-94
references: 19104406
references: J Heart Lung Transplant. 2007 Mar;26(3):205-9
references: 17346621
references: Transplant Proc. 2005 Mar;37(2):1333-9
references: 15848713
references: J Am Coll Cardiol. 2012 Apr 3;59(14):1263-9
references: 22464255
references: J Heart Lung Transplant. 2013 Mar;32(3):285-92
references: 23305695
references: Can J Surg. 1984 May;27(3):252-4
references: 6232993
references: J Heart Lung Transplant. 2005 May;24(5):517-25
references: 15896747
references: J Heart Lung Transplant. 2007 Oct;26(10):992-7
references: 17919618
references: Am J Transplant. 2006 Jun;6(6):1377-86
references: 16686761
references: Transplantation. 1994 May 27;57(10):1433-5
references: 8197602
references: Heart Fail Clin. 2007 Jan;3(1):31-41
references: 17545007
references: Transplant Proc. 1982 Dec;14(4):627-30
references: 6301117
references: J Heart Lung Transplant. 2004 Mar;23(3):272-6
references: 15019635
references: JAMA. 1973 Jul 16;225(3):288-91
references: 4577226
references: Am J Cardiol. 1995 Apr 15;75(12):853-4
references: 7717300
references: Am J Transplant. 2006 May;6(5 Pt 1):993-7
references: 16611335
references: J Am Coll Cardiol. 2005 May 3;45(9):1532-7
references: 15862430
references: Circ Heart Fail. 2011 Mar;4(2):129-37
references: 21216835
references: J Heart Lung Transplant. 2012 Oct;31(10):1052-64
references: 22975095
references: Transplantation. 1998 Aug 27;66(4):507-15
references: 9734496